Macrogenics Inc (MGNX)
4.37
-0.75
(-14.65%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.05
(+1.14%)
After-Hours: 20:00
Macrogenics Cash from Operations (Quarterly): -45.64M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -45.64M |
| December 31, 2023 | -28.04M |
| September 30, 2023 | -35.25M |
| June 30, 2023 | -2.089M |
| March 31, 2023 | -12.83M |
| December 31, 2022 | 29.32M |
| September 30, 2022 | -9.422M |
| June 30, 2022 | -49.16M |
| March 31, 2022 | -57.70M |
| December 31, 2021 | -54.31M |
| September 30, 2021 | -14.80M |
| June 30, 2021 | -45.69M |
| March 31, 2021 | -29.04M |
| December 31, 2020 | -5.533M |
| September 30, 2020 | -25.68M |
| June 30, 2020 | -36.55M |
| March 31, 2020 | -44.14M |
| December 31, 2019 | -38.04M |
| September 30, 2019 | -17.39M |
| June 30, 2019 | -48.84M |
| March 31, 2019 | -30.00M |
| December 31, 2018 | -27.23M |
| September 30, 2018 | -36.98M |
| Date | Value |
|---|---|
| June 30, 2018 | -57.73M |
| March 31, 2018 | -31.30M |
| December 31, 2017 | 111.84M |
| September 30, 2017 | -31.35M |
| June 30, 2017 | -30.76M |
| March 31, 2017 | -35.33M |
| December 31, 2016 | -28.33M |
| September 30, 2016 | 49.79M |
| June 30, 2016 | -33.23M |
| March 31, 2016 | -31.91M |
| December 31, 2015 | -24.16M |
| September 30, 2015 | -7.634M |
| June 30, 2015 | -25.46M |
| March 31, 2015 | 43.59M |
| December 31, 2014 | -20.16M |
| September 30, 2014 | -14.33M |
| June 30, 2014 | -4.15M |
| March 31, 2014 | 5.886M |
| December 31, 2013 | -1.184M |
| September 30, 2013 | 0.807M |
| June 30, 2013 | -9.946M |
| March 31, 2013 | -3.849M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-57.70M
Minimum
Mar 2022
29.32M
Maximum
Dec 2022
-28.54M
Average
-32.14M
Median
Cash from Operations (Quarterly) Benchmarks
| Moderna Inc | -989.00M |
| Allurion Technologies Inc | -8.636M |
| Novavax Inc | -83.56M |
| United Therapeutics Corp | 376.50M |
| MEI Pharma Inc | -2.928M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 24.79M |
| Cash from Financing (Quarterly) | 0.248M |
| Free Cash Flow | -113.88M |
| Free Cash Flow Per Share (Quarterly) | -0.7562 |
| Free Cash Flow to Equity (Quarterly) | -47.10M |
| Free Cash Flow Yield | -41.94% |